Kim Min Chan, Kim Sang Yun, Kim Kwan Woo
Department of Surgery, Dong-A University College of Medicine, Busan, Korea.
J Gastric Cancer. 2017 Dec;17(4):354-362. doi: 10.5230/jgc.2017.17.e40. Epub 2017 Dec 18.
Laparoscopic gastrectomy is accepted as a standard treatment for patients with early gastric cancer in Korea, Japan, and China. However, duodenal stump leakage remains a fatal complication after gastrectomy. We conducted a prospective phase II study to evaluate the safety of the new technique of laparoscopic reinforcement suture (LARS) on the duodenal stump.
The estimated number of patients required for this study was 100 for a period of 18 months. Inclusion criteria were histologically proven gastric adenocarcinoma treated with laparoscopic distal or total gastrectomy and Billroth II or Roux-en-Y reconstruction. The primary endpoint was the incidence of duodenal stump leakage within the first 30 postoperative days. The secondary endpoints were early postoperative outcomes until discharge.
One hundred patients were enrolled between February 2016 and March 2017. The study groups consisted of 65 male and 35 female patients with a mean age (years) of 62.3. Of these, 63 (63%) patients had comorbidities. The mean number of retrieved lymph nodes was 38. The mean operation time was 145 minutes including 7.8 minutes of mean LARS time. There was no occurrence of duodenal stump leakage. Thirteen complications occurred, with one case of reoperation for splenic artery rupture and one case of mortality.
Based on the results of this prospective phase II study, LARS can be safely performed in a short operation period without development of duodenal stump leakage. A future randomized prospective controlled trial is required to confirm the surgical benefit of LARS compared to non-LARS.
在韩国、日本和中国,腹腔镜胃切除术被视为早期胃癌患者的标准治疗方法。然而,十二指肠残端漏仍是胃切除术后的致命并发症。我们开展了一项前瞻性II期研究,以评估腹腔镜加强缝合术(LARS)用于十二指肠残端的新技术的安全性。
本研究预计在18个月内纳入100例患者。纳入标准为经组织学证实的胃腺癌,接受腹腔镜远端或全胃切除术以及毕罗II式或 Roux-en-Y 重建术。主要终点是术后30天内十二指肠残端漏的发生率。次要终点是直至出院的早期术后结局。
2016年2月至2017年3月期间共纳入100例患者。研究组包括65例男性和35例女性患者,平均年龄62.3岁。其中,63例(63%)患者有合并症。平均获取淋巴结数为38个。平均手术时间为145分钟,其中LARS平均时间为7.8分钟。未发生十二指肠残端漏。发生了13例并发症,1例因脾动脉破裂再次手术,1例死亡。
基于这项前瞻性II期研究的结果,LARS可在短手术时间内安全进行,且不会发生十二指肠残端漏。未来需要进行随机前瞻性对照试验,以证实LARS与非LARS相比的手术获益。